Format

Send to

Choose Destination
BMJ Case Rep. 2015 Oct 5;2015. pii: bcr2015209821. doi: 10.1136/bcr-2015-209821.

Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Author information

1
Department of Medicine, University of California, San Diego, La Jolla, California, USA.
2
Department of Anthropology, University of Kansas, Lawrence, Kansas, USA.

Abstract

We present a case series of four previously healthy, employed adults without significant prior medical history in each of whom symptoms developed while on fluoroquinolones (FQs), with progression that continued following discontinuation evolving to a severe, disabling multisymptom profile variably involving tendinopathy, muscle weakness, peripheral neuropathy, autonomic dysfunction, sleep disorder, cognitive dysfunction and psychiatric disturbance. Physicians and patients should be alert to the potential for FQ-induced severe disabling multisymptom pathology that may persist and progress following FQ use. Known induction by FQs of delayed mitochondrial toxicity provides a compatible mechanism, with symptom profiles (and documented mechanisms of FQ toxicity) compatible with the hypothesis of an exposure-induced mitochondrial neurogastrointestinal encephalomyopathy.

PMID:
26438672
PMCID:
PMC4600819
DOI:
10.1136/bcr-2015-209821
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center